Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil.

Authors: Filippis AM,Nogueira RM,Jabor AV,Schatzmayr HG,Oliveira JC,Dinis SC,Galler R,
Address: Departamento de Virologia, Laboratório de Flavivírus, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brazil 4365, 21045-900 Rio de Janeiro, RJ, Brazil. ambispo@ioc.fiocruz.br
Journal: Vaccine.


Publication: 2004 Mar 12;22(9-10):1073-8.

abstract

A mass vaccination was carried out in the state of Minas Gerais, Southeast region of Brazil, to control an outbreak of sylvatic yellow fever in 2001. during the outbreak the surveillance system identified two fatal cases temporally associated with YF vaccination. virus recovered from blood and postmortem samples of both cases was identified as yellow fever virus. Partial nucleotide sequence of parts of prM/E and the non-structural (NS) 5 genes and 3' non-coding region (3' NCR) was employed to characterize the origin of yellow fever virus (YFV) involved in both cases. wild-type YFV was identified as the etiologic agent responsible for the disease.



Related Articles
Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus.
J Med Virol. 2002
Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus.
de Filippis AM, Nogueira RM, Schatzmayr HG, Tavares DS, Jabor AV, Diniz SC, Oliveira JC, Moreira E, Miagostovich MP, Costa EV, et al. J Med Virol. 2002 Dec; 68(4):620-7.
Comparative phylogenies of yellow fever isolates from Peru and Brazil.
FEMS Immunol Med Microbiol. 2003
Comparative phylogenies of yellow fever isolates from Peru and Brazil.
Bryant JE, Barrett AD. FEMS Immunol Med Microbiol. 2003 Nov 28; 39(2):103-18.
Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.
Virology. 2001
Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.
Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LF, Cruz AC, et al. Virology. 2001 Nov 25; 290(2):309-19.
Review Yellow fever: a reemerging threat.
Clin Lab Med. 2010
Review Yellow fever: a reemerging threat.
Gardner CL, Ryman KD. Clin Lab Med. 2010 Mar; 30(1):237-60.
Review [Yellow fever virus].
Nihon Rinsho. 2003
Review [Yellow fever virus].
Kurane I. Nihon Rinsho. 2003 Mar; 61 Suppl 3:494-6.
Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States.
Am J Trop Med Hyg. 2010
Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States.
Monath TP. Am J Trop Med Hyg. 2010 May; 82(5):919-21.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.